Metabolix, Inc. (MBLX) Files Form 4 Insider Selling : William P Scully Sells 165,000 Shares

Metabolix, Inc. (MBLX): William P Scully , 10% owner of Metabolix, Inc. sold 165,000 shares on Sep 8, 2016. The Insider selling transaction was reported by the company on Sep 12, 2016 to the Securities and Exchange Commission. The shares were sold at $0.35 per share for a total value of $57,435.50 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Jan 7, 2016, William P Scully (10% owner) purchased 25,000 shares at $2.21 per share price.On Jun 23, 2015, Joseph H Shaulson (CEO) purchased 35,000 shares at $3.32 per share price.Also, On Jun 23, 2015, Walsem Johan Van (COO) purchased 12,000 shares at $3.32 per share price.On Jun 23, 2015, Oliver P Peoples (CSO) purchased 14,570 shares at $3.32 per share price.

Metabolix (MBLX) witnessed a volatile trading activity on Monday Sep 12, 2016 and eventually ended flat at 0.00% or 0 points without letting the bulls or bears take much advantage. The trading began at $0.3381 and reached the intraday high at $0.36. The bulls started the profit booking and pushed the shares to intraday low of $0.32. The trading session was marked by a volume range of 95,793 shares exchanging hands. The 52-week high of the shares is $3.98 and the 52-week low is $0.32. The market cap of the company stands at $9 M and there are 27,844,260 shares in public circulation.

Metabolix Money Flow Index Chart

Metabolix Inc. is an advanced biomaterials company. The Company is engaged in the business of developing and commercializing technologies for the production of polymers and chemicals in microbes and plants. It is focused on delivering solutions to the plastics industry. It has its operations in the microbial genetics fermentation process engineering chemical engineering polymer science plant genetics and botanical science. The Company offers three lines of products: biopolymers bio-based chemicals and crop-based technologies. Its biopolymers include performance additives and functional biodegradation products such as I6001 I6003rp Mirel a-PHA copolymer modifier Mirel Micropowders and Mirel P1003 F1005 for injection molding among others. The Company’s bio-based chemicals include Bio-based GBL/BDO and Bio-based Acrylic Acid. It also develops crop-based technology to co-produce renewable industrial chemicals with bioenergy in integrated bio refineries.

Leave a Reply

Metabolix - Is it time to Sell?

Top Brokerage Firms are advising their investors on Metabolix. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.